↓ Skip to main content

Dove Medical Press

Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells

Overview of attention for article published in Drug Design, Development and Therapy, January 2015
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
48 Mendeley
Title
Plumbagin elicits differential proteomic responses mainly involving cell cycle, apoptosis, autophagy, and epithelial-to-mesenchymal transition pathways in human prostate cancer PC-3 and DU145 cells
Published in
Drug Design, Development and Therapy, January 2015
DOI 10.2147/dddt.s71677
Pubmed ID
Authors

Jia-Xuan Qiu, Zhi-Wei Zhou, Zhi-Xu He, Ruan Jin Zhao, Xueji Zhang, Lun Yang, Shu-Feng Zhou, Zong-Fu Mao

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 48 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
India 1 2%
Brazil 1 2%
Unknown 46 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 8 17%
Student > Bachelor 7 15%
Student > Doctoral Student 7 15%
Researcher 5 10%
Other 3 6%
Other 8 17%
Unknown 10 21%
Readers by discipline Count As %
Agricultural and Biological Sciences 9 19%
Medicine and Dentistry 8 17%
Biochemistry, Genetics and Molecular Biology 6 13%
Pharmacology, Toxicology and Pharmaceutical Science 4 8%
Nursing and Health Professions 3 6%
Other 5 10%
Unknown 13 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 September 2015.
All research outputs
#22,759,452
of 25,374,647 outputs
Outputs from Drug Design, Development and Therapy
#1,754
of 2,268 outputs
Outputs of similar age
#306,533
of 359,538 outputs
Outputs of similar age from Drug Design, Development and Therapy
#48
of 57 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 359,538 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.